California State Teachers Retirement System (CalSTRS)
LCTX icon

California State Teachers Retirement System (CalSTRS)’s Lineage Cell Therapeutics LCTX Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,705
Closed -$4.83K – 3082
2025
Q1 		$4.83K Hold
10,705
– – ﹤0.01% 2916
2024
Q4 		$5.38K Hold
10,705
– – ﹤0.01% 2983
2024
Q3 		$9.69K Hold
10,705
– – ﹤0.01% 2883
2024
Q2 		$10.7K Sell
10,705
-2,636
-20% -$2.91K ﹤0.01% 2869
2024
Q1 		$19.7K Sell
13,341
-8,501
-39% -$9.64K ﹤0.01% 2723
2023
Q4 		$23.8K Sell
21,842
-6,633
-23% -$7.27K ﹤0.01% 2861
2023
Q3 		$33.6K Sell
28,475
-14,453
-34% -$19.7K ﹤0.01% 2850
2023
Q2 		$60.5K Buy
+42,928
New +$59.3K ﹤0.01% 2843
2022
Q2 		– Sell
-53,656
Closed -$83K – 3235
2022
Q1 		$83K Sell
53,656
-14,124
-21% -$21.9K ﹤0.01% 2917
2021
Q4 		$166K Buy
67,780
+2,577
+4% +$6.03K ﹤0.01% 2848
2021
Q3 		$164K Sell
65,203
-102,193
-61% -$262K ﹤0.01% 2816
2021
Q2 		$477K Buy
+167,396
New +$433K ﹤0.01% 2663
2020
Q2 		– Sell
-168,433
Closed -$139K – 3054
2020
Q1 		$139K Buy
168,433
+1,925
+1% +$1.92K ﹤0.01% 2706
2019
Q4 		$148K Hold
166,508
– – ﹤0.01% 2861
2019
Q3 		$163K Hold
166,508
– – ﹤0.01% 2854
2019
Q2 		$183K Sell
166,508
-7,818
-4% -$9.01K ﹤0.01% 2880
2019
Q1 		$228K Buy
174,326
+31,787
+22% +$39.5K ﹤0.01% 2715
2018
Q4 		$130K Sell
142,539
-14,107
-9% -$21.6K ﹤0.01% 2883
2018
Q3 		$322K Hold
156,646
– – ﹤0.01% 2680
2018
Q2 		$282K Buy
156,646
+3,726
+2% +$7.5K ﹤0.01% 2757
2018
Q1 		$360K Sell
152,920
-3,135
-2% -$7.35K ﹤0.01% 2537
2017
Q4 		$294K Buy
156,055
+19,879
+15% +$43.4K ﹤0.01% 2669
2017
Q3 		$338K Sell
136,176
-17,145
-11% -$42.5K ﹤0.01% 2620
2017
Q2 		$423K Sell
153,321
-14,630
-9% -$40.9K ﹤0.01% 2562
2017
Q1 		$507K Buy
167,951
+4,343
+3% +$12.3K ﹤0.01% 2480
2016
Q4 		$517K Sell
163,608
-4,572
-3% -$14K ﹤0.01% 2493
2016
Q3 		$574K Buy
168,180
+14,973
+10% +$41.4K ﹤0.01% 2420
2016
Q2 		$350K Buy
153,207
+15,150
+11% +$37.1K ﹤0.01% 2662
2016
Q1 		$347K Buy
138,057
+8,572
+7% +$19.1K ﹤0.01% 2625
2015
Q4 		$428K Buy
129,485
+12,092
+10% +$36.1K ﹤0.01% 2524
2015
Q3 		$284K Sell
117,393
-371
-0.3% -$960 ﹤0.01% 2771
2015
Q2 		$345K Buy
117,764
+530
+0.5% +$2.06K ﹤0.01% 2791
2015
Q1 		$470K Sell
117,234
-1,735
-1% -$6K ﹤0.01% 2486
2014
Q4 		$358K Buy
118,969
+510
+0.4% +$1.38K ﹤0.01% 2686
2014
Q3 		$300K Buy
118,459
+799
+0.7% +$1.92K ﹤0.01% 2727
2014
Q2 		$290K Buy
117,660
+35,188
+43% +$79.5K ﹤0.01% 2818
2014
Q1 		$219K Hold
82,472
– – ﹤0.01% 2854
2013
Q4 		$240K Hold
82,472
– – ﹤0.01% 2823
2013
Q3 		$253K Buy
82,472
+2,742
+3% +$8.68K ﹤0.01% 2784
2013
Q2 		$255K Buy
+79,730
New +$255K ﹤0.01% 2720

Other funds holding LCTX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
RA
Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s LCTX Position: Q2 2025 in Review

California State Teachers Retirement System (CalSTRS) sold out of Lineage Cell Therapeutics (LCTX) in Q2 2025, closing a stake of 10,705 shares — an estimated $4.83K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in LCTX in Q2 2013 and held it in 40 quarters. The position peaked at $574K in Q3 2016. 129 funds tracked by Wall St. Rank hold LCTX as of Q2 2025.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Lineage Cell Therapeutics position as of Q2 2025 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 10,705 Lineage Cell Therapeutics shares in Q2 2025, an estimated $4.83K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Lineage Cell Therapeutics in Q2 2013 and held it in 40 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Lineage Cell Therapeutics position peaked at $574K in Q3 2016.
  • 129 funds tracked by Wall St. Rank held Lineage Cell Therapeutics as of Q2 2025.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2025, filed 14 Aug 2025.